BRL 20627

promotes gastric emptying

Also Known As:

4-amino-5-chloro-2-hydroxy-N-(octahydro-6-methyl-2H-quinolizin-2yl)benzamide; BRL-20627; Benzamide, 4-amino-5-chloro-2-hydroxy-N-(octahydro-6-methyl-2H-quinolizin-2-yl)-, (2alpha,6beta,9aalpha)-(+-)-

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolizines: 1
      - BRL 20627: 1

Related Diseases

1.	Psychomotor Agitation (Akathisia) 05/01/1986 - "It is concluded that since the published animal data show that BRL 20627 has only weak dopamine antagonistic properties this study further implicates dopamine receptor blockade in the akathisia but not in the gastric effect of metoclopramide."

Related Drugs and Biologics

1.	Dopamine Receptors (Dopamine Receptor)
2.	Metoclopramide (Reglan)
3.	Dopamine (Intropin)